SOLID BIOSCIENCES INC's ticker is SLDB and the CUSIP is 83422E105. A total of 62 filers reported holding SOLID BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $472,000 | -45.9% | 1,012,270 | -28.7% | 0.00% | 0.0% |
| Q2 2022 | $873,000 | -42.6% | 1,418,931 | +11.9% | 0.00% | -50.0% |
| Q1 2022 | $1,522,000 | +43.0% | 1,268,575 | +108.7% | 0.00% | +100.0% |
| Q4 2021 | $1,064,000 | +10.8% | 607,828 | +51.3% | 0.00% | 0.0% |
| Q3 2021 | $960,000 | -31.8% | 401,845 | +4.4% | 0.00% | -50.0% |
| Q2 2021 | $1,408,000 | +150.1% | 384,785 | +418.2% | 0.00% | +100.0% |
| Q4 2020 | $563,000 | +184.3% | 74,250 | -24.0% | 0.00% | – |
| Q3 2020 | $198,000 | -48.2% | 97,652 | -25.2% | 0.00% | – |
| Q2 2020 | $382,000 | +84.5% | 130,500 | +50.8% | 0.00% | – |
| Q1 2020 | $207,000 | -19.8% | 86,551 | +49.1% | 0.00% | – |
| Q4 2019 | $258,000 | -22.8% | 58,040 | +79.7% | 0.00% | – |
| Q3 2019 | $334,000 | -61.3% | 32,300 | -78.5% | 0.00% | -100.0% |
| Q2 2019 | $864,000 | -2.6% | 150,300 | +55.9% | 0.00% | 0.0% |
| Q1 2019 | $887,000 | – | 96,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 7,929,918 | $13,877,000 | 1.10% |
| EcoR1 Capital, LLC | 9,202,702 | $16,105,000 | 0.51% |
| RA Capital Management | 12,367,873 | $21,644,000 | 0.38% |
| Perceptive Advisors | 26,825,104 | $46,944,000 | 0.36% |
| Boxer Capital, LLC | 3,177,702 | $5,561,000 | 0.22% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6,287,193 | $11,003,000 | 0.21% |
| Artal Group S.A. | 3,000,000 | $5,250,000 | 0.14% |
| Ikarian Capital, LLC | 521,155 | $911,000 | 0.14% |
| CAXTON ASSOCIATES LP | 177,571 | $311,000 | 0.03% |
| ALGERT GLOBAL LLC | 136,138 | $238,000 | 0.03% |